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of chemotactic migration in mesenchymal cells that can be selectively targeted in disease.
Here, we compare the chemotactic behavior, signaling and motility of mesenchymal and
amoeboid cells. We suggest that the current model of chemotaxis is applicable for small amoe-
boid cells but needs to be reconsidered for large mesenchymal cells. We focus on new candi-
date regulatory molecules and feedback mechanisms that may account for mesenchymal cell
type-specific chemotaxis.
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Chemotactic signaling 163IntroductionDirectional migration of intramural cells is fundamental for
tissue patterning and embryonic and postnatal develop-
ment. In adults, directional movement of immune cells into
sites of injury or infection is critical for the development of
an inflammatory response, subsequent wound healing and
tissue regeneration. The latter is provided by mesenchymal
cells that move into damaged areas, produce connective
tissue and maintain tissue homeostasis. These cells display
a common fibroblast-like appearance and characteristic
mode of migration. Hereafter, we focus on fibroblasts as
the prototypical mesenchymal cell and standard experi-
mental model. In addition, epithelial cancer cells dissemi-
nate by undergoing an epithelial-to-mesenchymal
transition to acquire a mesenchymal migratory phenotype.
Their directional migration is a hallmark of cancer metas-
tasis and the pathogenesis of autoimmune diseases. This
highlights the specificity and importance of the mesen-
chymal type of migration compared to the better under-
stood amoeboid migration. For this reason, we focus on the
mesenchymal-specific type of chemotaxis rather than
common molecular mechanisms that have been exhaus-
tively reviewed recently.1e5
Directional migration is based on the intrinsic propensity
of cells to persistently move in one direction without
turning.6 They can be ‘directed’ by various physical and
chemical stimuli, such as light, temperature, substrate ri-
gidity, matrix proteins, soluble substances, and so on.
These stimuli form asymmetric patterns that are detected
by cells and used as an external compass.7 Thus, this
directed type of migration ultimately involves the conver-
sion of asymmetrical external stimulants into internal gra-
dients of signaling molecules that in turn influence the
cytoskeleton that performs the motile responses.2,5
Chemotaxis is defined as directed migration of cells to-
wards a source of soluble chemical agents (chemo-
attractants) that bind to surface receptors and stimulate
cells to move. Chemotaxis involves 4 major components
(Fig. 1). First, cells detect chemoattractants and determine
the location of their source, a process known as directional
sensing. Second, cells process this information and transmit
it to the cytoskeleton by chemotactic signaling. Third, the
cytoskeleton undergoes asymmetric redistribution and
activation so that cells acquire a polarized morphology and
increase cell motility. Finally, cells perceive spatiotem-
poral changes in external gradients and adapt to them
through feedback mechanisms.
The lower eukaryotic amoeba Dictyostelium is a
commonly used model organism for studying chemotaxis
(www.dictybase.org).1,8 It has provided considerable
insight into chemotactic behavior, mechanisms of signal
reception and transduction inside cells.2 Importantly, these
mechanisms tend to be generally conserved in many cell
types of higher eukaryotes.9 They are almost identical in
amoeba-like neutrophils of higher vertebrates, which helps
to explain neutrophil biology and immune function in higher
organisms.
Fibroblasts are typically mesenchymal cells. Consistent
with physiological function,10,11 they clearly differ from
amoeboid cells in chemotactic and motile behavior.12e14However, they similarly perceive and process chemotactic
stimuli, and move using common machinery and principles
of motility as discussed below.
Here, we compare fibroblasts to amoeboid cells through
the four components of chemotaxis depicted in Fig. 1. The
major differences are summarized in Table 1 and are
detailed further in the text. We conclude that differences
in chemotactic signaling and, particularly, in feedback
mechanisms are most likely to account for differences in
the chemotactic behavior of these cells. Although fibro-
blasts have been found to lack the feedback loops that are
present in amoeboid cells, we suggest that they possess a
separate type of feedback that functions in the cytosol,
which is why it has not been detected with commonly used
membrane probes. We further suggest that hydrogen
peroxide may mediate this feedback downstream of
chemotactic receptors and activated Rac1.
Chemotactic behavior of mesenchymal cells
relative to amoeboid cells
According to the overall morphology and manner of move-
ment, cells are conventionally divided into two general
types: amoeboid and mesenchymal cells. Among them,
free-living amoeba Dictyostelium, intramural immune
neutrophils, and connective tissue fibroblasts are consid-
ered to be prototypical cells. They have clearly distinct
biology and functions that to a great extent explain their
morphology and behavior. Other cells, such as endothelial,
epithelial, neural, smooth muscle, primordial germ and
progenitor cells, as well various cancer cells, can be
broadly classified into one of the two above types by their
mode of migration and chemotactic behavior. However, the
mesenchymal type of migration is a hallmark of many
pathological states associated with aberrant cell migration.
Nonetheless, the mechanisms that regulate mesenchymal
cell migration are much less known or understood than
those of amoeboid cells. This lack of knowledge markedly
limits our ability to target these cellular components in
disease.
Amoeboid cells, such as fast moving neutrophils and
Dictyostelium, are most commonly used in studies of
chemotaxis. These cells have similar motile and chemo-
tactic behavior, are highly responsive to chemoattractants
and sensitive to changes in their gradients.15,16 They are
very small (10e20 mm) and can persistently move to a
source of chemoattractants with high speeds of up to
20 mm/min (i.e., one cell size a minute). Because they
constantly change shape, their type of migration is called
amoeboid.15,17
Amoeba Dictyostelium inhabits the soil and relies
completely on chemotaxis to fulfill nutritional and repro-
ductive needs.8 It feeds on bacteria, which it chases by
chemotaxis. When food runs out, the amoebae begin to
differentiate and aggregate into a single fruit body.18 They
move up the gradient of cyclic AMP, which they produce
and expel at the rear of the cell body to help followers
navigate into the assembly. Perhaps the most useful prop-
erty of the amoeba for researchers is its simple genome,
which has been sequenced and used to identify molecular
players in chemotactic migration.19
Figure 1 General organization of chemotactic migration. The four major modules of chemotactic migration are depicted.
Directional sensing occurs at the level of chemoattractant (ligand) binding to a chemotactic receptor and transmembrane signal
transduction at the level of second messengers. Then, chemotactic signaling transmits information to the cytoskeleton, where it
targets three major components of cell motility: protrusions, adhesions and contractility. Finally, feedback mechanisms regulate
sensitivity to external cues and mediate adaptive responses to changes in their gradients. See the text for details.
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mammalian chemotactic migration.16,20 Defense is their
primary function in an organism. They hunt invading bac-
teria by chemotaxis and mediate inflammatory responses.
Consistently, the major chemoattractants for neutrophils
are bacterially derived substances, such as formyl-
methionyl-leucyl-phenylalanine (fMLP) and lipopolysac-
charide (LPS), various inflammatory cytokines, and com-
ponents of a complement system, such as S5a.3 Neutrophils
distinguish between different chemoattractants to fulfill
their tasks. They are directed by several chemotactic gra-
dients, which they recognize in a preferential manner to
move interstitially for long distances.21 Additionally, both
neutrophils and amoebae have to react promptly to
changes in prey location. They both possess an effective
adaptive system, which provides a capacity for rapid re-
sponses in speed and direction of movement.3
In the absence of stimuli, the amoeboid Dictyostelium
and neutrophil cells have a rounded morphology and remain
stationary.22 When stimulated in a uniform manner (i.e.,
the entire membrane is equally accessible to chemo-
attractant), the cells start growing protrusions stochasti-
cally throughout the plasma membrane. Despite being
activated, the cells do not move because they cannot
temporally link successive protrusions at a single site on the
membrane, thus the cell body is not displaced in a single
direction. Occasionally, random displacement does occur
due to a predisposition of new protrusions to grow at the
base of previous ones, a phenomenon known as correlated
random walk.23,24
When a chemoattractant comes from a particular source
(i.e., in a gradient fashion), successive protrusions developon the side of the membrane facing the stimulus. They are
biased to this side through local upregulation of chemo-
tactic signaling and activation of the protrusive machinery.
As a result, cells persistently move in one direction with
increased speed. If the gradient changes direction, cells
respond by either biasing new protrusions to this new di-
rection and turning gradually or by growing a new protru-
sion and turning abruptly. The choice depends on the
strength of the external gradient, such that shallow gradi-
ents (i.e., weak stimulation) cannot effectively counteract
polarization and only induce gradual changes toward the
new direction. In contrast, steep gradients are sufficiently
strong to repolarize the cytoskeleton and induce new
formations.23,24
Polarization is the key event in directional motility. It
supports continuous growth of pseudopods at the cell front
and localizes contractile actomyosin bundles to the rear.
Whereas the cytoskeleton of unstimulated Dictyostelium
and neutrophil cells is inconspicuous and prone to remod-
eling, the cytoskeleton of fibroblasts is prominent and
developed.14 Thus, amoeboid cells have much more plas-
ticity than fibroblasts. Shallow chemotactic gradients
induce marked polarization in amoeboid cells, which can
easily repolarize if a gradient changes direction. This
feature allows immune leukocytes or free-living amoebae
to travel long distances and gather precisely at the source
of a pathogen or pheromone.
Fibroblasts are much larger and slower cells.25 They
move in a manner clearly distinct from amoeboid cells, but
in a manner that is characteristic of most mesenchymal
cells, which has been referred to as the mesenchymal type
of migration.16,26 Fibroblasts are highly adhesive and spread
Table 1 Major chemotactic differences between amoeboid and mesenchymal cells. GPCRs, G-protein-coupled receptors;
RTKs, receptor tyrosine kinases; PLA2, phospholipase A2.
Parameter Amoeboid cells Mesenchymal cells
Morphology Size 5e10 mm 50e150 mm
Native function Catching bacteria or finding
other cells
Reparing connective tissue at
the region of wound
Polarization time 30e60 s 30e50 min
Speed 10e20 mm/min 0.25e1 mm/min
Shape Non-spread cells, constantly
changing shape, usually a single
protrusion
Spread cells, fairly constant
shape, multiple protrusions
Protrusions Large relative to cell size:
filopodia, lamellipodia and
blebs
Local relative to cell size:
microspikes, filopodia,
lamellipodia, rarely blebs
Adhesiveness Weak Strong
Contractility Weak Strong
Chemotactic behavior Starved cells Not polarized and immobile Often intrinsically polarized
but immobile
Uniform stimulation Not polarized and immobile;
stochastic protrusions and
random migration possible
Intrinsic cues direct
polarization and migration
Gradient stimulation Rapid polarization and
chemotaxis along the gradient
Intrinsic polarization
counteracts external gradients
Directional sensing Simultaneously recognize
different chemoattractants in
the wide range of
concentrations; detect steep
and shallow gradients
Recognize single gradients in
midpoint concentration of
chemoattractant; detect only
steep gradients
Changing gradient direction Fast repolarization and turning Slow and partial reorientation
Chemotactic signaling Chemoattractants Microbial products, pathogen-
or damage-associated
molecular patterns,
components of complement
system, cAMP
Growth factors, extracellular
matrix proteins
Receptors GPCRs RTKs
Receptor-associated G-proteins Trimeric Gi and G12/13, the
bg-complex is important
Small Ras GTPase
Major signaling modules PI3 kinase/PIP3, PLA2, cGMP/
cAMP, mTORC2
PI3 kinase/PIP3, PLA2,
mTORC2, MAP-kinases, Src-
family tyrosine kinases
Cytoskeleton regulation Small GTPases Rac, Cdc42 and
Rho
Small GTPases Rac, Cdc42 and
Rho
Amplification step Second messenger level (i.e.
PIP3)
?
Cytoskeleton Actin microfilaments Dynamic actin cytoskeleton, no
stress fibers
Localized actin dynamics,
developed stress fibers
Microtubules ? Involved in polarization
Intermediate filaments ? ?
Feedback PAK1/PIXa-dependent Cdc42
activation and PIP3-dependent
Rac1 activation (ref.4)
?
Chemotactic signaling 1655-10 times larger than neutrophils. Their typical speeds are
approximately 0.25e1 mm/min,16,27 which means that they
require an hour to cover a distance of the cell length. This
brings into question what mechanisms these cells use to
maintain their direction of movement.Chemotactic behavior and regulation in fibroblasts is
consistent with their functions, which are distinct from
amoeboid cells. Fibroblasts act to maintain connective
tissue homeostasis and mediate wound healing.28 In a ho-
meostatic state at low or no stimulation, fibroblasts remain
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proteins of the extracellular matrix (a process known as
haptotaxis). When undergoing wound healing, fibroblasts
move into the wound by chemotaxis and mediate repair and
matrix remodeling. When in the wound, fibroblasts are
activated by a high absolute concentration of PDGF. As a
result, cells switch from persistent migration to prolifera-
tion. Their migration is directed by chemoattractants, pri-
marily platelet-derived growth factor (PDGF), which is
released upon damage and inflammation.28 Platelets, which
aggregate in wounded areas, produce extremely steep
gradients of PDGF. Fibroblasts do not need to locate the
source of PDGF precisely; they just migrate in the general
direction of the wound while producing matrix proteins.
Once in the wound, fibroblasts are exposed to a shallow-
gradient, high-concentration of PDGF (greater than 5 ng/
ml). They cannot effectively navigate in such conditions
and switch from migration to proliferation.29 Overall, this
behavior is consistent with the initial recruitment of these
cells to wounded areas, followed by an increase in the
number of cells, to accelerate wound healing.10
Additionally, fibroblasts are highly adhesive and sensi-
tive to protein composition and extracellular matrix rigid-
ity. They easily respond to the matrix by localized changes
in integrin-mediated signaling and cytoskeleton reorgani-
zation.30 When stabilized, these differences become
prominent between distant parts of these large, flat cells.
In this manner, internal asymmetry of the cytoskeleton and
overall cell polarity is established even in the absence of
chemoattractants. Together with other internal factors
(see Ref. 31), these mechanisms determine the intrinsic
polarity of fibroblasts.
In contrast to amoeboid cells, fibroblasts lack certain
mechanisms that help cell behavior adapt to altered stim-
ulation. They lack feedback circuits that are used by
amoeboid cells to amplify weak chemotactic signals,32
which helps to explain why fibroblasts are poorly sensitive
to shallow chemotactic gradients. In addition, they only
respond by chemotaxis to a certain range of chemo-
attractant concentrations, indicating that they adapt
poorly to altered stimulation. Due to these limitations, fi-
broblasts are often regarded as a stripped-down chemo-
tactic system.2
However, fibroblasts possess unique regulatory mecha-
nisms for migration and, perhaps, chemotaxis. Directional
migration of fibroblasts requires synthesis of b-actin at the
cell front.33 They can also locally sharpen PDGF gradients at
the cell front through receptor-dependent endocytosis.34
The internalized receptors continue to signal in endo-
somes, leading to activation of Rac1-induced actin dy-
namics at the cell front.35 Given such behavior, adjacent
fibroblasts move independently and randomly, yet persis-
tently as long as the self-induced gradient of PDGF is
maintained. Importantly, this intrinsic propensity of fibro-
blasts to develop and keep polarity, which is absent in
amoeboid cells, contributes significantly to their ability to
maintain direction and migrate persistently.36,37 Because of
this property, fibroblasts typically display an elongated
appearance with a broad leading and narrow rear lamellae,
even in the absence of stimulation.12,14 Shallow gradients
are not sufficient to counteract intrinsic polarity and
repolarize fibroblasts.32 Only steep gradients supportpersistent migration along a polarity axis, otherwise, fi-
broblasts repolarize and change direction in response to
adhesion to the extracellular matrix.
Thus, fibroblasts should not be considered as merely
simplified amoeboid chemotactic systems. They have
different functions and therefore different chemotactic
behaviors. These differences are both morphological, based
on distinct cytoskeletal organization, and functional due to
specific differences in intracellular signaling. The following
sections discuss the idea that signaling components play a
leading role in these differences.Cell motility
Morphologically, cell movement is commonly described by a
four-step migration cycle, which has been extensively
reviewed elsewhere.4,26,38,39 Briefly, it involves leading
protrusions, their attachment and adhesion formation,
translocation of the cell body, and rear detachment asso-
ciated with tail retraction. Remodeling of the actin cyto-
skeleton is the driving force for all types of motility,
including that of mesenchymal and amoeboid cells. The
tubulin (microtubule) cytoskeleton plays a lesser role in
motility; however, it is involved in setting up polarized
morphology.40
Protrusive activity at the cell front is determined by
increased actin dynamics via formation of a branched actin
filament meshwork.41,42 Translocation of the cell body and
tail retraction are predominantly mediated by the con-
tractile activity of internal stress fibers composed of actin
and myosin.43,44 Substrate adhesions couple these two
compartments and serve as mechanosensitive devices.45
When engaged with matrix proteins, these substrates bind
actin and promote actomyosin assembly and contractility,
which is then converted to traction. When disengaged, the
actin meshwork grows in the leading lamella.46 Basically,
cells coordinate protrusion and traction by alternating the
two events. In turn, substrate adhesions are reinforced by
contraction of the attached stress fibers.47 Thus, a positive
feedback circuit is involved in adhesion-dependent
motility: the more traction force that is generated by the
stress fibers, the harder the grip of the substrate
adhesions.37
This general model has been developed to describe
single cell migration on flat 2D-surfaces. Soon thereafter, it
was modified to fit within the 3D-context of physiological
milieu48 and further refined.49 While a few specialized
features have been added, such as integrin-independent
migration, contact guidance, cellular strategies to over-
come extracellular matrix resistance, and multicellular
migration, the basic four-step concept holds for single
cells. Several modes of migration have been defined, with
the amoeboid and mesenchymal serving as the two basic
types. However, a new paradigm has emerged that suggests
a balance between protrusive, adhesive and contractile
activities determines the mechanical mode of cell
migration.49,50
When protrusive activity dominates, single cells move
effectively by extending leading protrusions and dragging
the tail. Increased actin dynamics are sufficient to power
protrusions and, in extreme circumstances, traction.43
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‘blebbing’ mode of motility.51 They first extrude cyto-
plasmic fluid in the form of membrane bulges (blebs), which
are powered by hydrostatic pressure resulted from cortical
actomyosin contraction. Subsequently, the blebs fill with
the actin machinery and cytoplasm as a result of rear
contraction. Because contractility and adhesion are inti-
mately coupled,37,45 blebbing motility can also be viewed
as the adhesive mode of 2D-migration. However, in 3D-
lattices, many cells move in an integrin-independent
fashion purely by contraction-assisted blebbing
motility.52,53 In this case, compressed cells exert perpen-
dicular forces to the surrounding matrix and squeeze
themselves forward.51
According to the current multiparameter tuning model,
each cell type uses a particular ‘default’ mode of migration
but adapts to environmental cues by switching to other
modes when most apt for their circumstances.49,53 While
amoeboid cells mostly rely on protrusive and blebbing
modes, fibroblasts are adhesive and contractile. To move
efficiently, they undergo a mesenchymal-to-amoeboid
transition and then employ an amoeboid mode of
motility.49 This indicates that the composition and function
of the motile machinery is essentially the same for most
amoeboid and fibroblasts cells; however, it manifests
differently depending on the surrounding conditions.Directional sensing
The current concept of the mechanism by which cells
translate chemotactic signals into motile responses is that
the external gradients first coax into internal gradients of
signaling molecules, a process known as directional
sensing.2,5 These signaling molecules act as second mes-
sengers to activate downstream signaling pathways,
thereby leading to protrusions, adhesions and contractions,
which result in the asymmetric redistribution of the cyto-
skeleton and is known as polarization (Fig. 1).
Two quantitative parameters characterize spatial
gradient sensing.16 The first is sensitivity to the relative
steepness of the gradient or the degree of its slope. It is
usually given as a percent difference in the concentration
of chemoattractant across a cell. Expectedly, these values
are much smaller for amoeboid cells than for fibroblasts
due to cell size differences. Gradients are often called
steep or shallow to qualitatively define the inclination. The
second parameter is the average (midpoint) absolute con-
centration of a chemoattractant across a cell. This value
depends on, and changes with, the distance of the cell from
the chemoattractant source.
Chemotactic receptors are evenly distributed on the cell
surface of Dictyostelium54 and neutrophils,55 displaying
little or no preference for a leading membrane. Although
less data are available for fibroblasts,4 they apparently
display a similar trend. Further studies have demonstrated
that G-proteins, the immediate targets of chemotactic re-
ceptors, also have a distribution that matches the slope of
external gradients.56,57 These observations led to the
conclusion that activation, but not clusterization, of re-
ceptors and their downstream targets set up internal gra-
dients of signaling molecules. This is consistent with thechemotactic behavior of fibroblasts, which are not sensitive
to shallow gradients. Rather, they respond to steep gradi-
ents in the narrow range of midpoint concentrations of
chemoattractant.32 Low concentrations are insufficient to
activate chemotactic signaling above a threshold level,
whereas high concentrations activate signaling across the
entire membrane. Thus, fibroblasts perceive information
based on absolute concentrations of chemoattractant
rather than on the degree of the gradient slope.
By contrast, amoeboid cells discern the steepness of
gradients regardless of the midpoint value of the absolute
concentration of chemoattractant. They are equally
effective in navigating in steep and shallow gradients both
close and far from their source. Accordingly, these cells
must possess at least two specialized mechanisms that
enable this type of sensing and behavior. One mechanism is
‘thresholding’, which is the ability to subtract the minimum
level of signal induced in an exposed area by the lowest
absolute concentration of chemoattractant. This can
potentially be achieved via desensitization and down-
regulation of chemotactic receptors. The other mechanism
is ‘amplification’, which addresses shallow gradient
sensing. Small amoeboid cells experience little difference
in the concentration of chemoattractant across the length
of a cell. Thus, they must be amplified to achieve steep
internal gradients. As discussed above, this amplification is
achieved at the level of second messengers, downstream of
receptors and their immediate targets (see Fig. 1).
Different types of receptors mediate chemotaxis of
amoeboid and mesenchymal cells. Receptor tyrosine ki-
nases (RTKs) are used to sense gradients of growth factors,
which are the typical chemoattractants for fibroblasts.58
Among them, PDGF is the chief chemoattractant. Down-
stream signaling from PDGF receptors involves tyrosine
phosphorylation, binding of modular adaptor proteins and
activation of the monomeric G-proteins Ras, Rac, Rho and
Cdc42 (see Ref. 4 and references therein). Ras GTPase
functions as a primary hub to setj up chemotactic signaling
at the membrane. Rac and Cdc42 act at the cell front to
initiate membrane protrusions via regulated actin poly-
merization and dynamics.6 Rho GTPase functions in the rear
to regulate myosin filament assembly and contractility. The
reciprocity of Rac and Rho distribution and activation is
essential for polarization and chemotaxis.14,39
Amoeboid cells employ trimeric G-protein-coupled re-
ceptors (GPCRs) for chemotaxis. Although they differ in
subunit composition between lower and higher eukary-
otes,59 major chemotactic signaling occurs via the bg-
complex.57 Strikingly, both GPCRs and RTKs use the same
set of signaling pathways to stimulate chemotaxis. These
pathways similarly target small GTPases Ras, Rac, Rho and
Cdc42, leading to polarization and activation of the
cytoskeleton.39
Numerous studies have identified PI3-kinase signaling as
the major chemotactic cascade in both amoeboid and
mesenchymal cells (reviewed by Schneider and Haugh16 and
Vorotnikov4). The pathway is activated directly by chemo-
tactic receptors, with the participation of their immediate
G-protein targets: the bg-subunits of GPCR and Ras GTPase
for RTK. Although different PI3-kinase isoforms are
involved, they all generate a common PIP3 lipid that acts as
a universal secondary messenger in chemotaxis. Locally
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facing the gradient is essential to establishing its internal
gradient and cell polarity.
Live biosensor technology, especially the use of geneti-
cally modified fluorescent proteins,60 has been instru-
mental for imaging the dynamics of critical molecules
inside cells. Among these, the activation dynamics of the
Rho-family GTPases have been visualized to determine
their function in directional migration (reviewed by
Pertz61). Similarly, the intracellular dynamics of PIP3 have
been widely studied by translocation-based biosensors
composed of a fluorescent protein fused to isolated
pleckstrin-homology (PH) domains specific for PIP3 binding
(see Ref. 4 for references). These studies have unequivo-
cally demonstrated that internal PIP3 gradients are signifi-
cantly amplified in amoeboid cells compared to external
chemotactic gradients. In contrast, this amplification has
not been observed in fibroblasts.13 The final conclusion that
it is absent has been made on the basis of chemotactic
behavior modeling of fibroblasts.32 These results are
consistent with experimental data obtained by imaging of
PIP3 gradients in fibroblasts exposed to external gradients
of varying steepness and magnitude.
Notably, this fundamental difference becomes clearly
detectable at the second messenger level (see Fig. 1).
Upstream signaling is well conserved and shared by GPCRs
in amoeboid cells and RTKs in fibroblasts. Therefore, logic
dictates that amplified levels of PIP3 are achieved by spe-
cific mechanisms that are present in amoeboid cells but
absent in fibroblasts, either at or downstream from the
second messenger level. These mechanisms are thought to
involve specific redistribution of second messengers known
as LEGI, and downstream feedback circuits, respectively.
The local excitation and global inhibition (LEGI)model has
been suggested to explain directional sensing by small
amoeboid cells in which shallow external gradients produce
sharp excitation of internal gradients.2,5 In addition, LEGI
aims to explain the ‘thresholding’ phenomenon that renders
amoeboid cells independent from the midpoint concentra-
tion of chemoattractants. It assumes that directedmigration
becomes persistent when protrusive activity is stimulated at
the cell front and suppressed in the rear and lateral areas of
the cell. According to this hypothesis, chemoattractants
activate two types of signals. Strong activator molecules are
produced locally by self-enhancing regional excitation. They
diffuse slowly and accumulate in regions facing higher con-
centrations of chemoattractant. A lipid second messenger,
such as PIP3, perfectly meets these criteria because it is
confined to the membrane compartment and is boosted by
escalating enzyme-catalyzed reactions in the proximity of
activated chemotactic receptors. In contrast, the signal of
second type is weak and inhibitory. It spreads out rapidly and
acts at long range to cut off the activating signal everywhere
in the cell except for the leading membrane. Soluble second
messengers, such as cyclic nucleotides, are ideal for this
purpose because they are produced in a receptor-dependent
manner and quickly distribute throughout the cytoplasm.
Thus, superposition of these two signals provides the
required ‘thresholding’ of internal chemotactic signaling.
Thus restricted to the cell front, the rest of the activating
signal is subsequently amplified to yield a sharp internal
gradient.It is commonly accepted that PIP3 and cyclic nucleotides
play a key role in chemotaxis of most eukaryotic cells. PI3-
kinases that produce PIP3 are recruited to and activated by
chemotactic receptors.62 PIP3 demonstrates sharp internal
gradients in directionally migrating amoeboid cells55,63 and
fibroblasts.13 PIP3 acts as a local activator molecule that
recruits to the membrane proteins that contain PIP3-bind-
ing PH-domains. They include most of guanine nucleotide
exchange factors (GEFs) for Rac GTPase,64 which trigger
local activation of Rac and actin dynamics. On the other
hand, cyclic GMP is produced downstream of activated
chemotactic receptors in Dictyostelium,65 and cyclic AMP is
produced in neutrophils.66 The cyclic nucleotides seem to
distribute diffusely throughout the cytoplasm and exert
inhibitory functions.67 Cyclic GMP inhibits lateral pro-
trusions in Dictyostelium,65 whereas cyclic AMP inhibits
Rho-dependent activation of type II myosin and contrac-
tility in the cytoplasm.67 This is consistent with the LEGI
mechanism, with PIP3 functioning as the activating signal
and cyclic nucleotides as the inhibitory signal. However,
other signaling molecules cannot be excluded.
Whereas the LEGI model accounts for most of the
chemotactic behavior displayed by amoeboid cells, it has
limitations. For example, it poorly explains internal
gradient amplification and the stabilizing effect of cyto-
skeletal polarization as well as fibroblast chemotaxis. Thus,
feedback loops and adaptive mechanisms need to be added
to improve functionality. Some of these loops seem to be
absent in fibroblasts, while others are less active. On the
other hand, fibroblasts have much longer movement dy-
namics. To stabilize protrusions to maintain persistent
migration, chemotactic signaling needs to have longer ki-
netics. Protrusions in fibroblasts appear and disappear
stochastically unless stabilized by PIP3.
68 This suggests that
PIP3 levels must remain elevated longer in fibroblasts
compared to amoeboid cells and that the LEGI mechanism
may differ in fibroblasts to account for these temporal
needs. Whether specific feedback mechanisms can fulfill
this goal is discussed in the final section.Chemotactic signaling
Signaling pathways that regulate chemotaxis have recently
been extensively reviewed2,4,69 and will not be detailed
here. In brief, those identified so far include the PI3-
kinase/PIP3 module, phospholipase A2 (PLA2), guanylate/
adenylate cyclases and the cyclic nucleotide module,
mechanistic target of rapamycin complexes (mTORC1/2),
mitogen-activated protein (MAP) kinases, and the non-
receptor Src family of tyrosine kinases. Their relative
importance for chemotaxis is compared below.
The common characteristics of chemotactic signaling are
outlined in Fig. 1. Its major objective is to transmit external
signals picked up by chemotactic receptors to the cyto-
skeleton to activate three major motility components (pro-
trusion, adhesion, contraction) and initiate polarization.
When comparing chemotactic signaling across different cell
types, three specific aspects have to be emphasized.
First, chemotactic signaling is organized in two consec-
utive areas in all cells. The common part is composed of the
cell surface receptors and associated G-proteins, either
Chemotactic signaling 169trimeric for GPCRs or monomeric Ras GTPase for RTKs. This
enables transmembrane signal transduction and results in
rapid accumulation of activating and inhibitory second
messengers such as PIP3 lipids, cyclic nucleotides, Ca
2þ,
diacylglycerol, and others. Thereafter, chemotactic
signaling branches towards three major motility compo-
nents (Fig. 1). These branches signal Rho-family GTPases,
the master regulators of cytoskeletal dynamics,39 which
become asymmetrically distributed and activated along the
direction of the movement. Specifically, Cdc42 cooperates
with microtubules at cell tips to establish polarity; when
Cdc42 is defective, the directionality of migration is dis-
rupted. Rac stimulates actin dynamics in the leading
lamella, upregulating protrusive activity. Rho stimulates
myosin II assembly and activity, upregulating adhesions and
contractility.
Second, the same principal chemotactic pathways are
shared by both types of cells. Inasmuch as the balance
between protrusive, adhesive and contractile activities
determines the mode of migration chosen by a certain cell
type,48e50 chemotactic signaling aims to target a particular
component of motility. Thus, amoeboid cells that move by
protrusive motility would preferentially engage Rac-
mediated actin dynamics at the cell front. For this, the
PI3-kinase pathway is imperative. It provides local accu-
mulation of PIP3, recruitment of Rac GEFs, and Rac acti-
vation.62,64 The blebbing motility of amoeboid cells is
mostly supported by contractility; therefore, signaling to
actomyosin bundles in the cell body and rear would pre-
dominate. The guanylate cyclase/cyclic GMP system is
responsible for regulation of myosin II in Dictyostelium,70
while Rho GTPase and Rho-activated kinase regulate
myosin II in higher eukaryotes.39 Cyclic AMP is also involved
in setting up cell polarity by acting via Epac proteins and
Rap1 GTPase at the cell front and via Rho-mediated effects
on myosin in the rear.66 Finally, adhesion component that is
important for fibroblast migration is targeted by MAP-kinase
pathways71 and Src-family tyrosine kinases, including focal
adhesion kinase (FAK), Lyn, Fyn, Lck, and others.72
Third, another important aspect of chemotactic
signaling is that all signaling pathways are highly redun-
dant. This feature has been well illustrated with Dictyos-
telium as a chemotactic model (see Ref. 73 and references
therein). Even the PI3-kinase/PIP3 module that is often
regarded as critical for chemotaxis is dispensable in certain
situations.74 Thus, switching off a few, but not all,
chemotactic pathways at once may not fully disrupt
chemotaxis.75 This indicates that chemotactic pathways
can at least partially substitute for one another, which is
consistent with the plasticity of cell migration.49,50
Assuming that the motility components (protrusion, adhe-
sion and contractility) are interconnected, disruption of
signaling pathway(s) that activate one component is likely
to cause a cell to alter its mode of motility and use another
motility component to continue migration. Accordingly, the
cell engages a redundant signaling pathway to activate the
alternative component.
Finally, the mTORC pathway requires discussion as it has
recently emerged as a critical regulator of cell migration
(reviewed by Zhou and Huang76). mTOR is a ubiquitous ki-
nase involved in the regulation of cell growth, survival and
metabolism.77 It functions in two distinct signalingcomplexes, mTORC1 and mTORC2, which contain several
partially overlapping accessory and regulatory components.
Compromising the activity of any part of this complex
seriously affects cell migration, and the underlying molec-
ular mechanisms are just beginning to be discovered. In
Dictyostelium78 and neutrophils,67 mTORC2 is required for
directional migration; it functions via multiple pathways
that are mediated by protein kinase B/Akt, cyclic AMP and
Rho GTPase. Particularly, it seems to upregulate Rho ac-
tivity by activating Rho GEFs76; therefore, mTORC2 is a
potential regulator of cell contractility and adhesion. In
fibroblasts, mTORC2 also upregulates matrix metal-
loproteinases and remodeling of the extracellular matrix,76
which is specifically required for interstitial migration of
these cells.48
Thus, PI3-kinase/PIP3 is the major, but not unique,
signaling pathway to regulate chemotaxis. Other signaling
pathways exist and function in a redundant fashion. Over-
all, a great deal of similarity exists between amoeboid cells
and fibroblasts. Whereas some signaling pathway specificity
for a particular cell type may exist, it is unlikely to fully
account for different chemotactic behavior in these cells.
Rather, the activity of these pathways are coordinately
balanced and translated into activities of the protrusive,
adhesive and contractile components of motility as
required for the effective migration of a given cell type.Feedback and adaptation
Growing evidence suggests that fundamental differences in
the chemotactic behavior of amoeboid cells and fibroblasts
are due to feedback mechanisms that these cells employ to
sharpen internal gradients, modulate signaling kinetics and
adapt behavior to changes in external cues. These feedback
circuits are designed to resolve major issues experienced
while performing physiological functions. Amoeboid cells
have to travel long distances, perceive shallow gradients
independent of the midpoint concentration of chemo-
attractant, and respond effectively to changes in external
cues. Their small size allows for the rapid delivery of sec-
ond messengers to cell compartments but causes spatial
problems in segregating the activating and inhibitory sig-
nals. This problem is addressed by sharpening internal
gradients against external ones with the use of ‘threshold’
and ‘amplify’ functions at the second messenger level.
While the LEGI system is thought to provide for ‘thresh-
olding’ by an as yet unclear mechanism, two amplification
feedback loops have been found in Dictyostelium and
neutrophil cells (see Ref. 4 for details). The first involves
the activation of Cdc42, while the second involves activa-
tion of Rac GTPase. They are responsible for a biphasic
increase in actin polymerization and an actin-dependent
boost of PIP3 production at the cell front, resulting in
amplification of internal PIP3 gradients.
In contrast, fibroblasts move relatively short distances
and are vaguely navigated by stable and steep gradients of
chemoattractants that emanate from wounds. Due to their
elongated shape, fibroblasts experience large differences
in chemoattractant concentration over the length of the
cell and have little problem segregating internal activating
and inhibitory signals. For this reason, they lack the
Figure 2 Proposed feedback loop mediated by hydrogen
peroxide (H2O2). Shown is the fragment of PDGF signaling that
is mediated by PI3-kinase and PTEN and leads to PIP3 produc-
tion. In addition to conventional chemotactic pathway to Rac
GTPase and actin dynamics, PIP3 activates NOX assembly on
the plasma membrane both directly and via Rac. NOX produces
a superoxide anion radical, which is further converted to H2O2
as the final metabolite. H2O2 mediates potential feedback
loops to the PDGF receptor, PTEN and cytoskeletal proteins,
leading to maintained PDGF signaling and sustained migration.
See the text for details.
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Instead, fibroblasts have temporal problems due to slow
protrusion dynamics. To persistently move in one direction,
they need to keep the growth of successive protrusions on
one side of the cell.
Cells move by large protrusions (aka pseudopods); their
formation obeys the principles of self-organizing systems.79
Studies on Dictyostelium have demonstrated that in the
absence of chemotactic gradients, cells use correlated
random walk (i.e., they grow protrusions that tend to arise
close to previous ones).80 Pseudopods live through a certain
‘life’ cycle of extension, steadiness and retraction.
Chemotactic gradients affect the spatial characteristics of
pseudopods, but not their size, frequency, or duration of
growth.24 Thus, external gradients act to ‘link’ successive
pseudopods and bias their location toward the gradient. In
Dictyostelium, the average growth time and pseudopod
interval (period between the start times of two successive
pseudopods) are as short as 13 and 15 s, respectively.80 This
time frame requires that chemotactic signaling is
adequately reactive and responsive to changes in receptor
occupancy and gradient direction, which is necessary for
effective adaptation responses. Most signaling cascades,
including PI3-kinase, Src and MAP-kinase pathways, have a
2e4 min delay in peak activation as assessed by their target
readout after in vitro stimulation. This suggests that the
behavior of pseudopods is faster than signaling responses in
amoeboid cells, which may help to explain the fast adap-
tive responses in these cells.
By contrast, fibroblasts display a slow behavior of pro-
trusions that are responsible for cell body displacement.
These intervals are as long as 40e60 min,14 which is more
than two orders of magnitude longer than in amoeboid
cells. This suggests that chemotactic signaling must be
maintained long enough to ‘link’ two successive protrusions
and to enable the correlated random walk. These temporal
considerations become even more demanding for weakly
stimulated fibroblasts migrating in shallow gradients.
Recent studies using live imaging of PIP3 in randomly
moving fibroblasts demonstrated relatively short-lived sto-
chastic hot spots of PI3-kinase activity that were enriched
in regions of membrane protrusion and correlated with the
direction and persistence of fibroblast movement.68
Furthermore, distant hot spots were found to be dynami-
cally and stochastically coupled, which suggests that fi-
broblasts somehow convert rapid signaling events into long-
term directional migration.81 Although the molecular de-
tails of this conversion are presently unknown, a few issues
are worth noting. First, similar to amoeboid cells, a feed-
back or related circuit loop may maintain the activity of
chemotactic signaling at the cell front. Second, this is likely
to take place downstream of the second messenger level
(Fig. 1) because it is not detected by PIP3 sensors.
13,68
Third, such a circuit may not result in signal amplifica-
tion, but rather resolve the temporal problem of ‘linking’
successive protrusions. Finally, it has to be local and
confined to regions of receptor activity, thus avoiding the
need for a ‘thresholding’ system that is apparently absent
in fibroblasts.
Growing evidence suggests that hydrogen peroxide
(O2P2) acts as a second messenger in signaling downstream
of receptor tyrosine kinases.82,83 It plays a critical role incell proliferation,84,85 differentiation,86 apoptosis,87 and,
importantly, cell migration.82,88e90 We hypothesize that
O2P2 may be a missing link in the feedback circuits of fi-
broblasts (Fig. 2).
Using zebrafish as an animal model for chemotaxis,
Niethammer et al demonstrated that O2P2 forms tissue-
scale gradients around acute wounds to recruit leuko-
cytes.91 Blocking O2P2 production significantly delayed
leukocyte appearance in wounds. A follow-up study by Yoo
et al identified the non-receptor tyrosine kinase Lyn as an
intracellular target of O2P2 in leukocytes.
92 These studies
demonstrate that O2P2 is involved in the chemotaxis of
amoeboid cells.
The intracellular mechanism of O2P2 is thought to
involve the reversible oxidation of cysteine residues in the
active centers of a limited number of signaling enzymes.93
O2P2 is produced in cells in response to physiological
stimulation of RTKs (Fig. 2), which is in contrast to the non-
physiological oxidative effects of high O2P2 levels in
inflammation and disease.94
O2P2 accumulates in PDGF-stimulated fibroblasts.
89,95
In addition to the activation of conventional signaling
pathways, PDGF triggers the assembly of NADPH-oxidase
(NOX) complexes on the plasma membrane. Notably, this
activation independently requires Rac GTPase, PIP3 and/or
Chemotactic signaling 171protein kinase C,87 all of which are critical for fibroblast
chemotaxis.58 The major function of NOX is to produce
superoxide anion radicalP2
 . It is a short-lived precursor of
other reactive oxygen species that all metabolize into
relatively stable O2P2.
96
Tyrosine phosphatases are well known physiological
targets of O2P2 in cells because they contain an appro-
priate reactive cysteine residue in their active center.93,97
Among them, tyrosine phosphatase RTR-1C is the best
characterized.98 RTR-1C dephosphorylates and inactivates
the PDGF receptor as its major substrate. When oxidized by
O2P2, RTR-1C is transiently inactivated and PDGF signaling
is maintained. Lipid phosphatase PTEN, which de-
phosphorylates and inactivates PIP3 (Fig. 2), is another
target of O2P2.
99 Similar to RTR-1C, it is transiently inac-
tivated when oxidized by O2P2. In this case, PIP3 levels are
upregulated. Thus, O2P2-mediated inactivation of PTP-1B
and PTEN downstream of activated PDGF receptors may
potentially maintain chemotactic signaling by PDGF and
PIP3 in fibroblasts.
In addition to the inhibition of tyrosine phosphatases,
O2P2 has been shown to activate non-receptor tyrosine
kinases. In addition to the Lyn kinase mentioned above,
O2P2 also activates Src.
100 Given that Src is a critical
regulator of focal adhesions and that fibroblasts actively
use the adhesive component of motility, targeting Src by
O2P2 may specifically contribute to a mesenchymal vs.
amoeboid type of migration.
Finally, evidence demonstrates that O2P2 may act
further downstream at the cytoskeletal level (Fig. 2). It has
been suggested that cofilin, an early activator of actin dy-
namics, is activated via O2P2-mediated release of
Slingshot-1L phosphatase from its complex with the 14-3-3
scaffold protein.101 Two groups have also reported different
mechanisms of redox regulation that affect cysteine
oxidation and subsequent actin assembly.102,103
These observations lead us to hypothesize that O2P2
may act as an unrecognized activating secondary
messenger in the LEGI model. According to the LEGI
concept, the activating signal must be highly localized and
limited in diffusion.2,5 Consistent with these requirements,
we have recently shown that O2P2 is produced in the
cytoplasm and restricted to the endocytic compartment.95
This controlled and localized production potentially allows
O2P2 to escape degradation and toxic intracellular effects.
Whether intracellular O2P2 contributes to LEGI and
chemotaxis remains to be studied.Conclusions and future directions
The directional migration of mesenchymal cells is a po-
tential target in a variety of diseases. It is involved in both
physiological and pathological angiogenesis during cancer
progression. Cancer metastasis and dissemination involves
the epithelial-to-mesenchymal transition of cancer cells
and their intra- and extravasation by directional migration.
Wound healing undoubtedly requires fibroblast chemotaxis,
but hyperactivity of fibroblasts impairs regeneration and
results in scar formation. Regeneration of damaged areas
also depends on the effective recruitment of mesenchymal
precursor cells, which occurs via their directionalmigration. Thus, an approach is needed to selectively
target mesenchymal vs. amoeboid cell chemotaxis.
Despite being clearly different from amoeboid cells,
mesenchymal cell chemotaxis seems to use similar strate-
gies and common principles of directional sensing, chemo-
tactic signaling and cell motility. Therefore, parallels can
be drawn to identify key participants as potential thera-
peutic targets. We further reason that notable differences
appear at the level of feedback mechanisms, which are
specifically suited for the biology and physiological per-
formance of a given cell type. Identifying molecular players
in these mechanisms is a prerequisite for the future
development of means to selectively target mesenchymal
cell chemotaxis in disease.
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